Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Live Share Price Today, Share Analysis and Chart

Mid-range Performer

Iran war impact

The impact of the ongoing conflict and regional instability on Alivus Life Sciences Ltd. (formerly Glenmark Life Sciences Ltd.) is assessed as minimal to neutral from a direct operational standpoint, though it remains exposed to indirect macr...

986.45 16.65 (1.72%)

69,852

NSE+BSE Volume

NSE 25 Mar, 2026 12:17 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

55.7 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

1Yr Price target upside is 17%

Alivus Life Sciences Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

133 Votes:

Buy 75.19%

Sell 12.03%

Hold 12.78%